Qualifications either matter — for everyone — or they do not. Confirming an unlicensed nominee signals that standards are ...

Novartis becomes the second company to settle after being accused of reaping rewards from a racist medical system.

For too long, the promise of personalized therapies has been tantalizingly close, yet frustratingly out of reach for ...

It’s high time to change this and focus on sexual and reproductive health for men. Every single unplanned pregnancy involves ...

Minnesota hospitals and clinics participating in a controversial U.S. drug discount program reaped at least $1.34 billion in ...

FDA Commissioner Marty Makary defended the agency’s recent rejections of rare disease drugs and one of his deputies, Vinay ...

Scoop: Cigna has acquired CarepathRx, a large pharmacy backed by private equity that dispenses prescription drugs to nearly ...

SEC filings show that, at least for some drugmakers, "most-favored nation" drug pricing deals with President Trump last three ...

Exclusive: Harvard geneticist George Church knew more about Jeffrey Epstein's activities than he has previously said, before ...

As smoking rates fall in the U.S., startups and influencers are pushing the purported cognitive and health benefits of ...

A handful of states are considering initiatives to increase funding for scientific research as uncertainty around federal ...

Casey Means, now the epitome of a “MAHA mom," invokes motherhood and “wholeness” in health in making her case to be the U.S.